<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0017734"><a href="http://purl.obolibrary.org/obo/MONDO_0017734">MONDO:0017734</a></h3>
<p><strong>Label:</strong> sialidosis</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0009738">MONDO:0009738</a> (glycoproteinosis),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_812">Orphanet:812</a>, <a href="http://www.orpha.net/ORDO/Orphanet_87876">Orphanet:87876</a>, <a href="http://purl.obolibrary.org/obo/OMIM_256150">OMIM:256150</a>, <a href="http://purl.obolibrary.org/obo/OMIM_256550">OMIM:256550</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0012061">HP:0012061</a> (Urinary excretion of sialylated oligosaccharides) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_3000036">HP:3000036</a> (Abnormality of head blood vessel) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0100790">HP:0100790</a> (Hernia) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0100763">HP:0100763</a> (Abnormality of the lymphatic system) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0030680">HP:0030680</a> (Abnormality of cardiovascular system morphology) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0025408">HP:0025408</a> (Abnormal spleen morphology) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0025031">HP:0025031</a> (Abnormality of the digestive system) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0025015">HP:0025015</a> (Abnormal vascular morphology) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0012061">HP:0012061</a> (Urinary excretion of sialylated oligosaccharides) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0011443">HP:0011443</a> (Abnormality of coordination) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0011283">HP:0011283</a> (Abnormality of the metencephalon) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0011282">HP:0011282</a> (Abnormality of hindbrain morphology) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0011004">HP:0011004</a> (Abnormal systemic arterial morphology) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0010729">HP:0010729</a> (Cherry red spot of the macula) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) and <a href="http://purl.obolibrary.org/obo/HP_0010471">HP:0010471</a> (Oligosacchariduria) 75.00%</li>
</ul>
</body>
</html>
